Skip to content

Reimbursement for smoking cessation treatment.

The (cost)-effectiveness of reimbursement for smoking cessation treatment.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON29202
Enrollment
1266
Registered
2005-07-20
Start date
2002-05-01
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

For a period of 6 months, smokers in the intervention group had the opportunity to apply for reimbursement for SCT. They received a leaflet with a description of the SCTs for which reimbursement was a

Sponsors

None listed

Eligibility

Inclusion criteria

Inclusion criteria: We included smokers of at least 18 years old and healthcare insured by health insurance company "De Friesland Zorgverzekeraar". Participants did not have to be motivated to quit smoking.

Exclusion criteria

Exclusion criteria: Only one smoker per household was allowed to participate.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure of the reimbursement study was continuous abstinence from smoking. Continuous abstinence was defined as not having smoked for at least seven days preceding the 6-month and 12-month questionnaire and not having relapsed between both questionnaires. After the 6-month and 12-month questionnaire, quitters were contacted to make an appointment for biochemical validation of their smoking status.

Secondary

MeasureTime frame
Secondary outcomes were the use of smoking cessation treatment, the number of quit attempts that were undertaken, and the cost-effectiveness of reimbursement was assessed.

Contacts

Public ContactJ. Kaper

University Maastricht (UM), CAPHRI Research Institute, P.O. Box 616

janneke.kaper@hag.unimaas.nl+31 (0)43 3882420

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)